Literature DB >> 15016491

Hypothyroidism.

Caroline G P Roberts1, Paul W Ladenson.   

Abstract

Hypothyroidism is common, potentially serious, often clinically overlooked, readily diagnosed by laboratory testing, and eminently treatable. The condition is particularly prevalent in older women, in whom autoimmune thyroiditis is common. Other important causes include congenital thyroid disorders, previous thyroid surgery and irradiation, drugs such as lithium carbonate and amiodarone, and pituitary and hypothalamic disorders. Worldwide, dietary iodine deficiency remains an important cause. Hypothyroidism can present with nonspecific constitutional and neuropsychiatric complaints, or with hypercholesterolaemia, hyponatraemia, hyperprolactinaemia, or hyperhomocysteinaemia. Severe untreated hypothyroidism can lead to heart failure, psychosis, and coma. Although these manifestations are neither specific nor sensitive, the diagnosis is confirmed or excluded by measurements of serum thyrotropin and free thyroxine. Thyroxine replacement therapy is highly effective and safe, but suboptimal dosing is common in clinical practice. Patient noncompliance, drug interactions, and pregnancy can lead to inadequate treatment. Iatrogenic thyrotoxicosis can cause symptoms, and, even when mild, provoke atrial fibrillation and osteoporosis. We summarise present understanding of the history, epidemiology, pathophysiology, and clinical diagnosis and management of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016491     DOI: 10.1016/S0140-6736(04)15696-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  120 in total

1.  Heart rate variability and heart rate turbulence in hypothyroidism before and after treatment.

Authors:  Atac Celik; Pelin Aytan; Huseyin Dursun; Fatih Koc; Kerem Ozbek; Mustafa Sagcan; Hasan Kadi; Koksal Ceyhan; Orhan Onalan; Ersel Onrat
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

2.  The large eyes of Wolfgang Amadeus Mozart. (On the occasion of the 250th Mozart anniversary year).

Authors:  Richard H C Zegers; Peerooz Saeed; Wilmar M Wiersinga
Journal:  Int Ophthalmol       Date:  2007-02-06       Impact factor: 2.031

Review 3.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

4.  Myxoedema coma precipitated by diabetic ketoacidosis and neuroleptic drugs: case report in an intensive care unit.

Authors:  C Cappelli; B Stanga; A Paini; E Gandossi; D Cumetti; M Castellano; M L Muiesan; E Agabiti Rosei
Journal:  Intern Emerg Med       Date:  2007-07-18       Impact factor: 3.397

5.  Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats.

Authors:  C M López Fontana; L E Zyla; F E Santiano; C V Sasso; F D Cuello-Carrión; V Pistone Creydt; M A Fanelli; R W Carón
Journal:  Histochem Cell Biol       Date:  2017-02-13       Impact factor: 4.304

6.  Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.

Authors:  Rosarita Ferrara; Valentina Ientile; Vincenzo Arcoraci; Carmen Ferrajolo; Carlo Piccinni; Andrea Fontana; Salvatore Benvenga; Gianluca Trifirò
Journal:  Endocrine       Date:  2017-02-02       Impact factor: 3.633

7.  Increased thyroidal fat and goitrous hypothyroidism induced by interferon-gamma.

Authors:  Hiroaki Kimura; Miho Kimura; William H Westra; Noel R Rose; Patrizio Caturegli
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

Review 8.  Hypopituitarism.

Authors:  Paola Ascoli; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 9.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

10.  A forgotten but important risk factor for severe hyponatremia: myxedema coma.

Authors:  Ayse Kargili; Faruk Hilmi Turgut; Feridun Karakurt; Benan Kasapoglu; Mehmet Kanbay; Ali Akcay
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.